What Is a Good SMI for Muscle Health and Fitness?

A “good” skeletal muscle mass index depends on which formula is being used, your sex, and the population norms you’re compared against, but the most widely cited clinical benchmarks place healthy SMI at or above roughly 7.0 kg/m² for men and 5.5 kg/m² for women when calculated as appendicular skeletal muscle mass divided by height squared. Those thresholds mark the line below which muscle loss starts to carry measurable health risks, from higher mortality to metabolic trouble. The picture gets more complicated once you factor in ethnicity, body composition, age, and whether you care about clinical health or athletic performance.

What SMI Actually Measures

SMI stands for skeletal muscle mass index. At its core, it’s a way to standardize how much muscle you have relative to your body size, so that a taller person and a shorter person can be compared on a level playing field. The most common version divides the mass of your arms and legs (called appendicular skeletal muscle mass, or ASM) by the square of your height in meters. This produces a number in kg/m². Other versions adjust muscle mass by total body weight or by BMI instead of height.¹ These different adjustment methods don’t always agree with each other, which is one reason the “good” number you’ll find online varies depending on the source. The height-squared version is by far the most common in research and clinical practice, so unless stated otherwise, that’s the one being discussed here.

Clinical Cutoffs and Where They Come From

The numbers most often referenced in medical literature were developed to identify sarcopenia, the age-related loss of muscle mass and function that raises the risk of falls, fractures, and death. European consensus guidelines set the low-muscle-mass cutoff at an appendicular SMI below 7.0 kg/m² for men and below 5.5 kg/m² for women. One study aimed at validating these thresholds against a European older adult population found cut-off values of 9.2 kg/m² for men and 7.4 kg/m² for women.² That’s a substantial gap, and it illustrates something important: cutoffs shift depending on the reference population, the measurement device, and the statistical method used to draw the line.

If your SMI falls above these thresholds, you’re in the range considered adequate for clinical health. But “adequate” and “good” aren’t the same thing. For a 30-year-old who lifts weights regularly, having an SMI that just clears a sarcopenia cutoff designed for 70-year-olds is not especially reassuring. These values are floors, not targets.

How SMI Is Measured

Two tools dominate: dual-energy X-ray absorptiometry (DXA) and bioelectrical impedance analysis (BIA). DXA is considered the reference standard. It uses low-dose X-rays to separate bone, fat, and lean tissue. BIA sends a small electrical current through your body and estimates muscle mass based on how well your tissues conduct it. BIA devices range from medical-grade machines in clinics to consumer scales you can buy online.

The practical question is whether BIA gives you reliable enough numbers. The answer is a qualified yes. Studies comparing the two methods find high correlations between BIA and DXA, but BIA consistently overestimates muscle mass. One study in hospitalized older adults found a strong positive correlation between the two methods in both men and women, and concluded that BIA was accurate enough for clinical screening purposes.³ However, another cross-sectional study found that agreement between BIA and DXA was actually quite low when assessed by a stricter statistical method, with BIA overestimating appendicular lean mass by about 1.75 kg/m² on average.⁴ A third study found BIA overestimated whole-body muscle mass by about 2.3 kg and appendicular muscle mass by about 2 kg compared to DXA, even though the correlation between methods was very high.⁵

What this means for you: if you get your SMI measured on a BIA device (including most smart scales), your number is probably somewhat inflated. That matters less for tracking changes over time and more when you try to compare your reading to a published cutoff that was derived using DXA. When in doubt, assume your BIA-based SMI is a bit higher than your “true” DXA value, and focus on trends rather than absolute numbers.

Why Your SMI Matters for Longevity

Low muscle mass isn’t just an aesthetic concern. A systematic review and meta-analysis of prospective cohort studies found that people in the lowest muscle mass category had about a 57% higher risk of dying from any cause compared to those with normal muscle mass.⁶ That’s a pooled estimate across multiple studies, and it held up after adjusting for common confounders.

A large U.S. population study found a clear dose-response pattern: as SMI climbed from the lowest to the highest quintile, mortality dropped in a stepwise fashion. Every 20-percentile increase in SMI was linked to about a 14% lower risk of death from all causes.⁷ In other words, more muscle wasn’t just better than rock-bottom; each incremental gain came with a survival advantage, up to a point.

The mortality picture gets worse when low muscle mass combines with other deficits. In older adults with heart failure, having both low SMI and reduced bone density more than doubled the mortality rate compared to those with normal values for both. Having just one of those problems in isolation wasn’t statistically significant on its own.⁸ The combination effect matters because muscle and bone tend to decline together, as we’ll see shortly.

SMI and Metabolic Health

Skeletal muscle is your body’s largest glucose sink. When you have more of it and it’s working properly, your tissues pull sugar out of the bloodstream more efficiently. Lower muscle mass has been linked to higher insulin resistance, higher blood sugar markers, and greater diabetes risk. A cross-sectional study using a large population sample found that people in the highest SMI quartile had about 21% lower odds of diabetes compared to those in the lowest quartile, after adjusting for confounders.⁹

A Korean national survey found that sarcopenia roughly doubled the risk of diabetes and metabolic syndrome in non-obese individuals, particularly among older adults.¹⁰ Interestingly, the relationship was less clear in the obese group, suggesting that excess body fat may mask or overwhelm the metabolic signal from muscle mass alone. One study even found that using total muscle mass as a percentage of body weight was a better indicator of insulin resistance than the standard height-squared SMI in people with type 2 diabetes.¹¹ This hints at an ongoing debate about which adjustment method (height, weight, or BMI) gives the most clinically meaningful picture.

The Sarcopenic Obesity Problem

One of the trickiest scenarios is when someone has low muscle mass but high body fat. A normal or elevated BMI can hide significant muscle depletion underneath. This combination, sometimes called sarcopenic obesity, appears to carry risks beyond what either condition produces on its own. Among patients already diagnosed with sarcopenia, those with a high fat mass ratio had a nearly fourfold increase in all-cause mortality risk compared to those without excess fat.¹²

A study of cancer patients made this point even more starkly. Low muscle index and low muscle density were both independently prognostic of survival, regardless of whether the patient appeared obese, overweight, normal-weight, or underweight by conventional measures. Patients who had all three poor body-composition markers (high weight loss, low muscle index, and low muscle density) survived a median of about 8 months, versus about 28 months for those who had none of these features.¹³ BMI alone was a terrible predictor compared to body-composition variables. If you rely only on a bathroom scale, you can miss serious muscle depletion hiding behind a reassuring weight.

Muscle Quantity Versus Muscle Quality

A high SMI doesn’t guarantee that your muscles are working well. Research has shown that muscle quality, measured as strength per unit of muscle mass, is a separate and sometimes more important predictor of function than sheer size. In one large study, people with high muscle quality had lower odds of physical impairments regardless of their SMI. Meanwhile, people with high muscle mass but low quality had elevated odds of impairments.¹⁴ This finding was particularly relevant for older adults, whose muscles can become infiltrated with fat even as total mass stays stable. A study tracking sarcopenia and cognitive decline found that muscle function was the stronger predictor of incident Alzheimer’s disease and cognitive decline; lean mass alone was not associated with these outcomes once function was accounted for.¹⁵

So if you’re interested in a “good” SMI from a health perspective, don’t treat it as a number to maximize in isolation. Pair it with some measure of function, even informal ones like grip strength, how fast you can walk, or how easily you can stand from a chair. The modern sarcopenia consensus criteria already require low function alongside low mass before making a diagnosis, which reflects this reality.

How Ethnicity Shifts the Goalposts

One universal SMI cutoff doesn’t work across populations. A study comparing German, Mexican, and Japanese adults at the same BMI found that Germans had the highest SMI, while the pattern for the other groups varied by weight status. Fat distribution, muscle distribution across the trunk versus limbs, and hydration patterns all differed between groups.¹⁶ The authors emphasized that both obesity and sarcopenia diagnostics need ethnicity-specific reference values.

Within Asian populations, the variation is also large. A descriptive comparison of sarcopenia-related measurements across multiple Asian countries found considerable variation that didn’t fall into any neat pattern by ethnicity or geography.¹⁷ Similarly, muscle quality indices differed by both sex and race in a U.S. sample, with non-Hispanic Asian individuals scoring higher and non-Hispanic Black individuals scoring lower compared to non-Hispanic white participants.¹⁸ If you’re comparing your SMI to a published cutoff, check which population it was derived from. A threshold based on European data may overdiagnose sarcopenia in a smaller-framed Asian individual, or miss it in someone with a larger frame.

What Athletic SMI Looks Like

The clinical cutoffs exist to identify dangerous muscle loss, not to describe optimal fitness. For people who train seriously, the relevant question isn’t “am I above the sarcopenia floor?” but “how much muscle can I realistically carry?” Research examining athletes across various sports found that their fat-free-mass index and skeletal muscle index were substantially higher than in non-athlete controls, with the difference in SM index running about 56%. The SM index in large athletes appeared to plateau at roughly 17 kg/m² beyond a body mass of about 120 kg.¹⁹ That plateau suggests a biological ceiling, even in people who are genetically selected and pharmacologically assisted. For a recreational lifter, an SMI in the range of 9 to 12 kg/m² for men or 7 to 9 kg/m² for women would represent an above-average amount of muscle, well clear of any health concern and approaching the territory where performance and aesthetics, rather than health, become the primary motivators.

Sex Hormones, Aging, and Muscle Decline

Men generally carry more muscle mass than women, and this gap widens with age. Age-related decline in skeletal muscle area is steeper in men than in women.²⁰ Sex hormones play a central role. Intramuscular testosterone levels are lower in older men than in younger men, while the hormonal picture in women around menopause is less clear-cut.²¹

A study using U.S. national survey data found that in women, the highest estradiol levels were associated with about 56% lower odds of having low muscle mass compared to the lowest levels. In the same study, each unit increase in free testosterone in women was also associated with lower odds of low muscle mass. Higher levels of sex-hormone-binding globulin, which reduces the availability of free hormones, were associated with greater odds of low muscle mass in both sexes.²² The practical takeaway: age-related hormonal changes are one of the major drivers of falling SMI, and the pattern differs between men and women.²³ A “good” SMI at age 70 is biologically harder to maintain than the same number at age 30, which is part of why age-specific reference ranges matter.

Building and Maintaining SMI Through Exercise

Resistance training is the single most reliable way to raise or preserve your SMI. A meta-analysis focused specifically on people with sarcopenia found a statistically significant positive effect of resistance training on muscle mass.²⁴ The effect was modest in size, which makes sense given that sarcopenic older adults are working against hormonal decline, chronic disease, and sometimes poor nutrition, but it was consistent and meaningful.

For younger, healthy adults, the evidence is straightforward: progressive overload works regardless of whether you increase resistance through heavier loads or more repetitions, and both approaches produce similar gains in muscle size.²⁵ Long-term consistency is critical. In a study tracking older adults through 80 weeks of resistance exercise, appendicular lean mass increased by about 3.5%, with dramatic improvements in muscle cross-sectional area.²⁶ Those gains accumulated over nearly two years of training, not two months. If you’re aiming to meaningfully change your SMI, think in terms of sustained effort over many months.

What You Eat and When You Eat It

Protein intake is widely understood to support muscle mass, but the distribution of protein across the day appears to matter as well. In research examining how meal-by-meal protein distribution relates to muscle mass, people who consumed a greater share of their daily protein at breakfast had higher SMI and grip strength than those who loaded most of their protein into dinner.²⁷ A study of healthy Chinese older adults found that a more even spread of protein across meals was linked to better appendicular muscle mass. Women who had two or more meals per day reaching about 0.4 grams of protein per kilogram of body weight showed higher relative muscle mass compared to those who didn’t hit that threshold at any meal.²⁸

The evidence here is still observational and cross-sectional, so it doesn’t prove that rearranging your meals will directly boost your SMI. But it aligns with the broader understanding that muscle protein synthesis responds best when amino acids arrive in adequate doses several times a day, rather than in one large bolus at dinner. For someone trying to protect or build muscle, spreading protein intake more evenly is a simple, low-risk strategy.

Bone Health and the Muscle-Bone Connection

Muscle and bone share a mechanical relationship. Muscles pull on bones, and those forces stimulate bone remodeling. When muscle mass drops, the stimulus to maintain bone density drops with it. A longitudinal study in older adults found that a clinically meaningful decline in SMI was associated with roughly double the odds of losing bone density at the spine, hip, and femoral neck, and nearly quadruple the odds of deteriorating bone microarchitecture.²⁹ In postmenopausal women with osteoporosis, SMI was positively correlated with bone mineral density at the hip and femoral neck.³⁰

This is one reason why maintaining a good SMI matters for reasons beyond muscle itself. The downstream effects on bone integrity can determine whether a fall in old age results in a bruise or a broken hip.

Muscle Mass and Cognitive Decline

An emerging line of research connects skeletal muscle mass to brain health. A longitudinal study of Chinese older adults found that higher muscle mass was protective against cognitive impairment, with the relationship following a nonlinear pattern. For older men, an SMI below about 7.2 kg/m² was a risk factor for cognitive impairment; for older women, the threshold was about 5.4 kg/m².³¹ A Canadian longitudinal study found that low appendicular lean mass was independently associated with faster decline in executive function over three years, though not with memory.³²

The mechanisms likely involve shared pathways: chronic inflammation, reduced blood flow, lower production of muscle-derived signaling molecules that support brain health. The evidence is still being assembled, but it’s another reason why letting SMI slide into the low range may have consequences beyond the musculoskeletal system.

Emerging Drug Therapies for Muscle Loss

For people who can’t exercise enough to offset severe muscle loss, pharmacological options are under investigation. Research into drugs targeting myostatin (a protein that limits muscle growth), exercise-mimicking compounds, anabolic hormones, and various natural compounds is ongoing.³³ None of these are approved standard treatments for age-related muscle loss yet. Some agents show promise in specific clinical situations: in spinal cord injury, for example, certain compounds like beta-2 agonists appear to slow muscle wasting more effectively than traditional anabolic agents.³⁴ For now, resistance training and adequate protein remain the frontline interventions for most people, but the pharmaceutical pipeline suggests that additional tools may become available in the coming years for those who need them most.